MYL9 Antibodies

Santa Cruz Biotechnology delivers a wide array of MYL9 monoclonal antibodies for investigating MYL9 in various biological processes. MYL9 monoclonal antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MYL9, also known as myosin light chain 9, functions as a critical component of the contractile apparatus in smooth muscle and non-muscle cells, playing a vital role in muscle contraction and cellular motility. MYL9 regulation is essential for various physiological processes, including cell division, migration, and tissue remodeling. Dysregulation of MYL9 has been implicated in several diseases, making it an important target for research. Understanding MYL9's role in cellular processes can lead to breakthroughs in therapeutic strategies. Studying MYL9 expression patterns helps reveal its involvement in various signaling pathways. Research into MYL9 continues to uncover new aspects of cellular function and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of MYL9's role in health and disease.